CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-10-23: Form 8-K; Period of report 2017-10-23; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2017-10-10: Form 8-K; Period of report 2017-10-10; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2017-09-06: Form 8-K; Period of report 2017-09-05; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2017-07-24: Form 8-K; Period of report 2017-07-24; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-10-23 | 8-K | 2017-10-23 | 2.02 Results of Operations and Financial Condition | 2.02 On October 23, 2017, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2017. | clb-2017q3_earningsrelease.htm |
| 2017-10-10 | 8-K | 2017-10-10 | 7.01 Regulation FD Disclosure | 7.01 On October 10, 2017, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on October 20, 2017 and payable November 21, 2017. | clb-8k_dividend4q2017.htm |
| 2017-09-06 | 8-K | 2017-09-05 | 7.01 Regulation FD Disclosure | 7.01 On September 5, 2017, Core Laboratories N.V. issued a press release announcing revisions to previously issued earnings guidance for its quarter ending September 30, 2017, as a result of the impact of Hurricane Harvey to our operations. | a2017-09x05xform8xk.htm |
| 2017-07-24 | 8-K | 2017-07-24 | 2.02 Results of Operations and Financial Condition | 2.02 On July 24, 2017, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2017. | clb-2017q2_earningsrelease.htm |
| 2017-07-06 | 8-K | 2017-07-06 | 7.01 Regulation FD Disclosure | 7.01 On July 6, 2017, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on July 17, 2017 and payable August 14, 2017. | clb-8k_dividend3q2017.htm |
| 2017-05-22 | 8-K | 2017-05-22 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 18, 2017 in Amsterdam, The Netherlands. | a2017annualshareholdermeet.htm |
| 2017-04-19 | 8-K | 2017-04-19 | 2.02 Results of Operations and Financial Condition | 2.02 On April 19, 2017, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2017. | clb-2017q1_earningsrelease.htm |
| 2017-04-18 | 8-K | 2017-04-18 | 7.01 Regulation FD Disclosure | 7.01 On April 18, 2017, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on April 28, 2017 and payable May 23, 2017. | clb-8k_dividend2q2017.htm |
| 2017-01-25 | 8-K | 2017-01-25 | 2.02 Results of Operations and Financial Condition | 2.02 On January 25, 2017, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2016 and full year ended December 31, 2016. | clb-2016q4_earningsrelease.htm |
| 2017-01-10 | 8-K | 2017-01-10 | 7.01 Regulation FD Disclosure | 7.01 On January 10, 2017, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on January 20, 2017 and payable February 17, 2017. | clb-8k_dividend1q2017.htm |